Guardian Pharmacy Services, Inc.
GRDN
$33.66
-$0.44-1.28%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 156.39% | 146.14% | -487.61% | -389.95% | -465.19% |
| Total Depreciation and Amortization | 12.96% | 12.49% | 10.15% | 9.51% | 8.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.59% | -82.39% | 870.65% | 2,143.58% | 1,084.01% |
| Change in Net Operating Assets | 121.70% | 126.79% | -432.11% | -381.41% | -288.48% |
| Cash from Operations | 72.97% | 75.36% | -14.14% | 7.96% | -18.16% |
| Capital Expenditure | -19.41% | -35.47% | -43.34% | -27.33% | -12.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 8.80% | -21.76% | -19.23% | -1,393.40% | -1,393.40% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.69% | -60.60% | -64.23% | -60.01% | -68.05% |
| Cash from Investing | -5.98% | -36.94% | -42.96% | -141.34% | -126.23% |
| Total Debt Issued | -- | -100.00% | -70.85% | -45.70% | -24.19% |
| Total Debt Repaid | 97.93% | 81.44% | 50.41% | 28.13% | 11.61% |
| Issuance of Common Stock | -75.76% | -75.76% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 69.44% | 26.57% | 6.17% |
| Other Financing Activities | 97.06% | 92.31% | -336.79% | -324.46% | -347.28% |
| Cash from Financing | 70.10% | -580.82% | 81.41% | 57.73% | 58.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,459.85% | -102.01% | 1,888.38% | 3,573.62% | 2,595.17% |